eg110a
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2024 (NCT06596291)
Timeline
No events for the selected filters.
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07227285 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2026 | — |
| NCT06596291 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2024 | Department of Defense |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 1 | 0 | 1 | 2024 |
1 organizations
Page 1 / 1